コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 imilar concentrations of IL-7 detected in RA synovial fluid.
2 sphatidylcholine type phospholipids in human synovial fluid.
3 lymph nodes, and later after infusion in the synovial fluid.
4 HMVEC migration and/or tube formation by RA synovial fluid.
5 ation of activated human T cells toward this synovial fluid.
6 e turnover were examined in serum, urine, or synovial fluid.
7 cytes using interleukin-1 and osteoarthritic synovial fluid.
8 duces the induction of HMVEC migration by RA synovial fluid.
9 uid compared with RA serum or osteoarthritis synovial fluid.
10 8 was higher in RA synovial fluid than in OA synovial fluid.
11 tes at the concentrations detected in the RA synovial fluid.
12 ly reduced monocyte migration mediated by RA synovial fluid.
13 7 is expressed in the RA synovial tissue and synovial fluid.
14 gly correlated with the level of gp96 in the synovial fluid.
15 suggesting that cleaved OPN is released into synovial fluid.
16 at the alpha-enolase was citrullinated in RA synovial fluid.
17 are common components of osteoarthritis (OA) synovial fluid.
18 ative method for identifying BCP crystals in synovial fluid.
19 se-beta) are present in rheumatoid arthritis synovial fluid.
20 the quantities of synthetic BCP crystals in synovial fluid.
21 able methods for identifying BCP crystals in synovial fluid.
22 aracterization of exosomes miRNAs from human synovial fluid.
23 tics and were pre-coated with human blood or synovial fluid.
24 gands, CXCL9 and CXCL10, are elevated in PsA synovial fluid.
25 tic tool had low sensitivity when applied to synovial fluid.
26 gradation and release of components into the synovial fluid.
27 ricant and chondroprotective glycoprotein in synovial fluid.
28 lated with the total leukocyte counts in the synovial fluids.
30 including the blood, peritoneal fluid, bone, synovial fluid, a perianal abscess, and an arm wound.
31 CXCL10/CXCR3 axis, with CXCL10 increasing in synovial fluids after injury and Cxcr3(-/-) mice being p
32 ound that HA contributes to the formation of synovial fluid aggregates, and HysA can disrupt aggregat
33 tractants CCL15 and CCL23 by incubation with synovial fluid, although the responsible proteases could
34 Current methods of diagnosing SA rely on synovial fluid analysis and culture which are known to b
35 endation: ACP recommends that clinicians use synovial fluid analysis when clinical judgment indicates
36 vated levels of PGE(2) have been reported in synovial fluid and cartilage from patients with osteoart
37 tion of cleaved chemerins was much higher in synovial fluid and cerebrospinal fluid samples than in p
38 vides high signal intensity in cartilage and synovial fluid and is a promising technique for imaging
39 Quantification of calreticulin in plasma and synovial fluid and of calreticulin-FasL binding was perf
40 hic arthritis to both mononuclear cells from synovial fluid and PBMC fails to reduce the production o
41 ts receptor was significantly elevated in RA synovial fluid and peripheral blood macrophages as well
46 splant 21 months prior to presentation whose synovial fluid and surgical specimens grew Phomopsis bou
47 showed gross and analytical improvements in synovial fluid and synovial membrane, with increasing re
48 is an important modulator of TNF-alpha in RA synovial fluid and that TLR5 expression on these cells s
49 odulating transcription of TNF-alpha from RA synovial fluid and the strong correlation of TLR5 and TN
51 ronic acid (HA) is abundant in cartilage and synovial fluid and widely thought to play a principal ro
52 tals are common components of osteoarthritic synovial fluids and define subsets of patients with infl
53 ugh proteomic and transcriptomic analyses of synovial fluids and membranes from individuals with oste
55 ls of inflammatory biomarkers, both locally (synovial fluid) and systemically (serum and plasma).
56 cimens, including cerebrospinal fluid (CSF), synovial fluid, and abscess tissue, from 469 case patien
60 uingly, the repertoires of FOXP3(+) Tregs in synovial fluid are highly overlapping with CD25(+)FOXP3(
61 elevated concentration of PTX3 in plasma and synovial fluid as compared with healthy and osteoarthrit
62 ity of proteins showed overexpression in JIA synovial fluid as compared with noninflammatory control
65 eived antibiotics within the month preceding synovial fluid aspiration (48 of whom had PJI), PCR pane
66 ein we show that CCL15 is processed in human synovial fluid by matrix metalloproteinases (MMPs) and s
67 d BMP-2 productions were measured in patient synovial fluids by enzyme-linked immunosorbent assay.
68 en the 2 patient groups were observed in the synovial fluid CD4+CD25(high) population, a cell subset
75 ion of sJAM-C is also elevated locally in RA synovial fluid compared with RA serum or osteoarthritis
80 TLR-5 to endogenous ligands expressed in RA synovial fluid contributed to endothelial cell infiltrat
82 radiographic tests, such as serum urate and synovial fluid crystal analysis and radiographic or ultr
84 piration (48 of whom had PJI), PCR panel and synovial fluid culture sensitivities were 64.5% and 85.4
91 of both pathways can more strongly impair RA synovial fluid-driven monocyte migration and osteoclast
93 ed septic joints should be aspirated and the synovial fluid examined by microscopy for the presence o
96 ling, and reports newly identified serum and synovial fluid FAs as predictive biomarkers of OA in obe
97 These results highlight the importance of synovial fluid for the expression of citrullinated autoa
99 scent sera from 91 EM patients, in serum and synovial fluid from 141 LA patients, and in serum from 5
100 describe the evaluation of culture-negative synovial fluid from a 3-year-old boy by PCR and electros
101 IL-17 is involved in neutrophil recruitment, synovial fluid from arthritic joints showed a comparable
102 (HCs) with hyaluronan was first described in synovial fluid from arthritic patients and later describ
104 nd this process was prevented by addition of synovial fluid from JIA patients, through an IL-6-indepe
105 ontaining proteins and hemolytic activity of synovial fluid from patients suffering from rheumatoid a
106 g revision surgery were higher than those in synovial fluid from patients undergoing primary surgery.
108 rmally produced by the chemokines present in synovial fluid from patients with active rheumatoid arth
109 ated T cells toward the chemokine mixture in synovial fluid from patients with active rheumatoid arth
110 rullinated polypeptides were detected in the synovial fluid from patients with RA and patients with S
111 ge were detected by Western blot analysis in synovial fluid from patients with rheumatoid arthritis a
113 ated SOX5 levels were higher in synovium and synovial fluid from RA compared to osteoarthritis patien
114 cellular PLA(2) activity was detected in the synovial fluid from rheumatoid arthritis and gout patien
117 and naturally occurring chemoattractants in synovial fluid from the rheumatoid synovium, including C
120 were isolated by affinity chromatography of synovial fluids from patients with rheumatoid arthritis,
128 , with increasing regulatory macrophages and synovial fluid IL-10 concentrations compared with saline
131 tivated inflammasomes and the association of synovial fluid IL-18 with OA progression, lend strong su
132 y both radiograph and bone scintigraphy, and synovial fluid IL-1beta was associated with OA severity
137 llular matrix of all body tissues, including synovial fluid in joints, in which it behaves as a filte
138 It is assumed that the interaction with synovial fluid in the biocompartment leads to significan
141 Neutralizing anti-JAM-C Abs inhibited RA synovial fluid-induced HMVEC chemotaxis and sJAM-C-induc
144 rical items, physical examination, serum, or synovial fluid laboratory data for diagnosing septic art
146 o determine the associations among serum and synovial fluid lipid levels with OA, synovitis, adipokin
147 eins are a prerequisite for agglomeration in synovial fluid, low activity of the Agr regulatory syste
153 ermore, expression of TLR5 is elevated in RA synovial fluid macrophages and RA peripheral blood monoc
154 ealthy donors and treated with TNF and using synovial fluid macrophages derived from patients with RA
155 ecursors obtained from mouse bone marrow and synovial fluid macrophages derived from RA patients were
158 The expression of TLR2, but not TLR4, on synovial fluid macrophages strongly correlated with the
160 l, interquartile range [IQR] 14.8 ng/ml) and synovial fluid (median 10.3 ng/ml, IQR 12.0 ng/ml) of RA
161 plasma (median 3.1 ng/ml, IQR 1.3 ng/ml) and synovial fluid (median 2.9 ng/ml, IQR 0.9 ng/ml) of pati
162 17-producing T cells in peripheral blood and synovial fluid mononuclear cells from 36 children with J
163 CCL4, CCL5, CXCL9, and CXCL10; all levels in synovial fluid obtained from patients undergoing revisio
165 hai protein, and neutrophil migration toward synovial fluid of arthritis patients was inhibited by tr
168 process was also effective for HC-HA in the synovial fluid of human rheumatoid arthritis patients (i
169 essed on macrophages in vitro and in vivo in synovial fluid of inflamed paws, whereas expression is r
170 56(bright)CD16(-) NK cells isolated from the synovial fluid of juvenile idiopathic arthritis patients
171 Although leukotrienes are present in the synovial fluid of Lyme disease patients, their role in t
172 how that the HC-HA complex is present in the synovial fluid of mice subjected to systemic and monoart
173 SPADE was used to analyze EVs present in the synovial fluid of patients with inflammatory arthritis.
174 PBMC and mononuclear cells obtained from the synovial fluid of patients with juvenile idiopathic arth
177 e-linked immunosorbent assays, we tested the synovial fluid of patients with RA, osteoarthritis (OA),
178 andins (PGs) are found in high levels in the synovial fluid of patients with rheumatoid arthritis, an
179 1alpha was found in peri-implant tissues and synovial fluid of people with failing Metal-on-Metal hip
180 d whether IgA immune complexes in plasma and synovial fluid of RA patients activate neutrophils.
181 Herein, we studied macrophages from the synovial fluid of RA patients and observed a significant
184 plex with complement component C4d in pooled synovial fluid of rheumatoid arthritis (RA) patients.
185 The RANKL/OPG ratio was disrupted in the synovial fluid of RRV patients, and this was accompanied
189 The concentration of adrenomedullin in the synovial fluid of untreated Lyme arthritis patients was
190 cesses and mediate leukocyte adhesion in the synovial fluids of arthritis patients and protect agains
192 cells, leukemic cells, and granulocytes from synovial fluids of patients with rheumatoid arthritis.
193 d the effects of IL-1beta and osteoarthritic synovial fluids on anabolic gene expression and increase
194 e and (iv) exposure to body fluids (blood or synovial fluid) on release kinetics and efficacy of anti
201 Pa was lower in RA synovial fluid than in OA synovial fluid (P < 0.05; n = 8), and free IL-18 was hig
202 gnificantly higher concentrations of ECGF in synovial fluid (P<0.0001) and more often had ECGF antibo
205 e purpose of this study was to delineate the synovial fluid proteome and determine whether protein ex
208 duced suppression is due to resistance of RA synovial fluid responder T cells to Treg inhibition.
213 ic PCR assay panel using 284 prosthetic knee synovial fluid samples collected from patients presentin
216 Here, clinical records, radiographs, and synovial fluid samples from 30 dogs that sustained RCCL
220 ated levels of OPN-R and OPN-L were found in synovial fluid samples from RA patients, but not in samp
222 um-specific PCR testing was performed on all synovial fluid samples to confirm the U. parvum detectio
225 Vitamin A metabolite levels were elevated in synovial fluid, serum, and cartilage from patients with
227 )) is an abundant mucin-like glycoprotein in synovial fluid (SF) and a major component responsible fo
229 sed by enzyme-linked immunosorbent assays in synovial fluid (SF) and serum samples obtained from pati
232 0 patients with erythema migrans (EM) and in synovial fluid (SF) from 63 patients with Lyme arthritis
233 lasma, serum, cerebrospinal fluid (CSF), and synovial fluid (SF) from both preclinical species and hu
234 lly bound to C4d were identified from pooled synovial fluid (SF) from four rheumatoid arthritis (RA)
235 ostic utility of the SACOL0688 antigen using synovial fluid (SF) from humans with orthopedic implant
236 and usually presents as multiple bands when synovial fluid (SF) from OA patients is analyzed by zymo
237 ther a TLR-2- or TLR-4-stimulating factor in synovial fluid (SF) from patients with early knee OA wit
240 ), and sulfated glycosaminoglycans (sGAG) in synovial fluid (SF) lavage specimens and synovial tissue
242 from peripheral blood mononuclear cells and synovial fluid (SF) macrophages were determined by tartr
243 enumerated in the peripheral blood (PB) and synovial fluid (SF) of 12 patients with antibiotic-refra
245 + monocytes in the peripheral blood (PB) and synovial fluid (SF) of patients with RA were investigate
247 nd subjected to relative lateral motion with synovial fluid (SF) or phosphate buffered saline (PBS) a
249 ine the functional roles of one of the major synovial fluid (SF) T cell subsets, Vgamma9(+)Vdelta2(+)
250 idence time of hyaluronan (HA) in knee joint synovial fluid (SF) was investigated using a rabbit ante
251 CD4+ T cells from the peripheral blood (PB), synovial fluid (SF), and synovial tissue of RA patients.
253 tly demonstrated that mechanical shearing of synovial fluid (SF), induced during joint motion, rapidl
254 nally strong biofilmlike aggregates in human synovial fluid (SF), to an extent significantly exceedin
260 -time PCR, we studied 24 blood samples and 2 synovial fluid specimens from 20 patients with persisten
261 pray ionization mass spectrometry applied to synovial fluid specimens had an 81% sensitivity and a 95
262 g 379 retrospective, remnant whole-blood and synovial fluid specimens previously submitted to Associa
263 of CD4 T cells in 2 samples of inflammatory synovial fluid, suggesting a potential role in the patho
266 taneous CXCL13 secretion were detected in RA synovial fluid T cells but were not detected (or were de
269 riguingly, the LMW form was more abundant in synovial fluid than in serum from both rheumatoid arthri
270 PG(Bb), which is significantly higher in the synovial fluid than in the serum of the same patient.
273 e real-time PCR and sequencing to culture of synovial fluid, tissue, and sonicate fluid for the micro
276 t of subjects with knee osteoarthritis (OA), synovial fluid uric acid was strongly correlated with sy
280 urement of nitrite/nitrate in the plasma and synovial fluid was carried out by chemiluminescence assa
282 flammatory cells involved in osteoarthritis, synovial fluid was collected early after disease inducti
284 itionally, expression of both CPB and C5a in synovial fluid was higher in patients with RA than in th
287 Of the galectin family members present in synovial fluid, we find that galectin-3 is a specific, h
293 ules, including PRELP, are released into the synovial fluid where they may interact with components o
294 BCS serves as an in vitro substitute for the synovial fluid which forms a lubricant in the actual ort
295 ng the diagnostic utility of quantifying the synovial fluid white cell count, with two recent systema
296 nts derived from cartilage and released into synovial fluid will allow discrimination between differe
297 by lubricin (LUB), a component of mammalian synovial fluid with excellent antifouling properties, th
298 survival and suggest that supplementation of synovial fluid with lubricin may be an effective treatme
299 table in fetal bovine serum, human serum and synovial fluid, with varying levels of instability obser
300 les, six clinical specimens (five blood, one synovial fluid) yielded an atypical oppA1 PCR product, b